Symptoms, symptom burden, and influencing factors in patients treated with Nivolumab
Nivolumab-related symptoms are influenced by both treatment-related and individual lifestyle factors. Adequate nutrition and avoiding concurrent chemotherapy may help reduce symptom severity.
Authors
- Fatih Özdemir (ORCID: https://orcid.org/0000-0003-0292-3602)
- Melike ÇELİK (ORCID: https://orcid.org/0000-0002-5405-0084)
- Gülbeyaz Can (ORCID: https://orcid.org/0000-0002-5368-0893)
- DİLEK YILDIRIM
Institutions
- Istanbul Aydın University (TR)
- Istanbul University-Cerrahpaşa (TR)
- Izmir Atatürk Eğitim ve Araştırma Hastanesi (TR)
- Muğla University (TR)
Publication Details
- Journal
- Immunotherapy
- Published
- 2026-01-02
- DOI
- https://doi.org/10.1080/1750743x.2026.2626243
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00